![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22839-22846, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 26, 2002, and in revised form, April 2, 2002
Staphylococcal enterotoxins are
superantigen exotoxins that mediate food poisoning and toxic shock
syndrome in humans. Despite their structural and functional
similarities, superantigens display subtle differences in biological
properties and modes of receptor binding as a result of zinc atoms
bound differently in their crystal structures. For example, the crystal
structures of the staphylococcal enterotoxins in the type C serogroup
(SECs) contain a zinc atom coordinated by one aspartate and two
histidine residues from one molecule and another aspartate residue from
the next molecule, thus forming a dimer. This type of zinc ligation and
zinc-mediated dimerization occurs in several SECs, but not in most
other staphylococcal enterotoxin serogroups. This prompted us to
investigate the potential importance of zinc in SEC-mediated
pathogenesis. Site-directed mutagenesis was used to replace SEC zinc
binding ligands with alanine. SEC mutants unable to bind zinc did not
have major conformational alterations although they failed to form
dimers. Zinc binding was not essential for T cell stimulation,
emesis, or lethality although in general the mutants were less
pyrogenic. Thus the zinc atom in SECs might represent a non-functional
heavy atom in an exotoxin group that has diverged from related
bacterial toxins containing crucial zinc atoms.
The staphylococcal enterotoxins
(SEs)1 are proteins belonging
to a family of bacterial pyrogenic toxins produced by
Staphylococcus aureus and Streptococcus pyogenes
(1). The SEs cause at least two human illnesses, staphylococcal food
poisoning (SFP) and toxic shock syndrome (TSS) (1, 2). Although
the pathogenesis has not been completely elucidated for either disease,
TSS results from the superantigen (SAg) activity of the SEs, toxic
shock syndrome toxin-1 (TSST-1), or other pyrogenic toxins. SAgs are
potent immune cell stimulators and induce the proliferation of T cells
in a manner that depends on the V Although TSS and staphylococcal food poisoning have overlapping
symptoms, the pathogenesis of each is unique, and the biological activities responsible for both diseases are determined by separate regions of the SE molecules (7-9). The route of exposure also determines which disease will result. TSS requires systemic exposure to
any pyrogenic toxin, whereas staphylococcal food poisoning results from
SEs in the gastrointestinal tract following ingestion in food (2). The
hallmark symptom, emesis, can be accompanied by other effects including
diarrhea and abdominal cramping. Evidence suggests that SEs interact
with receptors on mast cells, and further that neuropeptides generated
contribute to the emetic response (10-12).
Although the number of recognized SEs continues to grow, these
classical SEs (SEA through SEH) can be divided into general subgroups
based on the degree of sequence homology. SEA, SED, SEE, and SEH share
higher sequence homology and form one subgroup, whereas SEB and SECs
forms another subgroup. The SECs are a highly related heterogeneous
group of serologically cross-reactive but distinct molecular variants
produced by some staphylococcal species, particularly S. aureus and S. intermedius isolates from several animal
hosts (13). The amino acid sequences of the SEC molecular variants
share more than 90% identity.
One conserved property of the SECs is their ability to bind zinc (14,
15). Although several SAgs bind zinc, their mechanisms for
zinc ligation vary and are usually
different from that of SECs (Table
I). The
SEC zinc binding mechanism is similar to that of metalloproteases such
as thermolysin. Three residues in the SECs (His-118, Glu-119, and
His-122) form a motif (HEXXH), which provides two of the
zinc binding ligands. Interestingly, zinc was not found in the
structure of SEB (16, 17), which shares 86% sequence homology with
SECs. The zinc ligation in the crystal structures of SEA (18, 19), SED
(20), SEE (21), and SEH (22) is found at a different site on the
external face of the Crystallization and Data Collection of the Native
Protein--
Native SEC3 was purified directly from the
Staphylococcus sp. FRI-909 strain (23).
Homogenous SEC3 protein preparations were crystallized into two crystal
forms, both of which diffracted to atomic resolution (24). The
structure presented in this present report was determined from the
tetragonal crystal form (P4122) with unit cell dimensions
of a = b = 43.7 Å and
c = 280.5 Å, with one molecule in the asymmetric unit.
The native data set to 2.6 Å was collected at room temperature with a
Xentronics/Siemens multiwire area director coupled to an Elliot-20
rotating anode generator and processed using the XDS package (25).
Construction and Purification of Zinc Binding Site
Mutants--
A commercial kit (Altered Sites II in vitro
mutagenesis systems, Promega) was used to create site-specific
mutations in secMNDON, allowing the expression
of mutant toxins containing alanine substitutions at one or more of the
three positions in SEC1 occupied by zinc binding residues (Asp-83,
His-118, His-122). Five different mutant genes were constructed; three
encoding proteins with single alanine substitutions and two with double
alanine substitutions. The mutant toxins expressed by these genes were
designated SEC1(D83A), SEC1(H118A), SEC1(H122A), SEC1(D83A/H118A),
and SEC1(D83A/H122A) based on the amino acid positions involved. For
expression, each mutant gene or native secMNDON
was subcloned into the chimeric shuttle vector pMIN164 and then
transformed via protoplast transformation into the non-toxigenic
background of S. aureus RN4220 as described previously (26,
27). Recombinant toxins were purified to apparent homogeneity from
culture supernatants by preparative isoelectric focusing as described
previously (26). Size and purity of each toxin and mutant were assessed
by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
(see below).
Electrophoresis--
SEC1 and various mutants (typically 1-10
µg) were resolved by denaturing, discontinuous, SDS-PAGE in 12.5%
gels using established techniques (28), with the minor modification of
adding 10% glycerol to the resolving gel. Proteins were visualized in
the gels by staining with Coomassie Blue. Prestained size markers were
used as standards. For native gel experiments, ~5 µg of each toxin, SEC1 and SEC1(D83A/H122A), was loaded onto a continuous native, 12.5%
polyacrylamide gel. The gel system used was equivalent to the
denaturing gel system above except that SDS was omitted from both the
gel and tank buffer, and the sample buffer contained no
Gel Filtration--
Purified SEC1 or SEC1(D83A/H122A) (125 µg
each) were loaded onto a Sephadex G-75 column equilibrated with 10 mM phosphate, 150 mM NaCl, and 10 mM ZnCl2. Monomer and dimer forms of the toxins were eluted and detected as a change in absorbance at 280 nm. Molecular
weight markers were used to determine the size of eluted proteins.
Zinc Binding Assessment--
To assess the effect of each
mutation on the ability of SEC1 to bind zinc, native SEC1 and each of
the five mutant proteins were compared under identical conditions.
After exhaustive washing of each protein with buffer (2 mM
HEPES, pH 7.0) using a Centricon 10 filter (Amicon, Beverly, MA), the
retentates were analyzed for zinc content by ICP MS (Inductively
Coupled Plasma Mass Spectrometry) using an ISA/Jobin Yvon model JY24
with a high efficiency nebulizer (29).
T Cell Proliferation Assays--
To determine the effect of zinc
or zinc binding residues on the activity of SEC1 as a SAg, SEC1 or
mutants were compared for their abilities to induce proliferation of
human T cells. Incorporation of [3H]thymidine into
cellular DNA during stimulation in culture was used as an index for
lymphocyte proliferation (30). Purified mutant toxins or native SEC1
were added to T-lymphocyte-enriched cultures in complete RPMI 1640 medium and incubated at 37 °C in 7% CO2 for 72 h.
Cultures were pulsed (18-24 h) with 1.0 µCi of [3H]thymidine. Cellular DNA was harvested on glass fiber
filters, and the level of radioactivity incorporated was quantitated by liquid scintillation counting.
Rabbit Model Experiments--
The rabbit model described by Kim
and Watson (31) was used to compare lethality and fever induced
in vivo by SEC1 and several selected mutants as an
indication of their potential to induce fever and TSS. Each animal
(adult New Zealand White rabbit) was given an initial intravenous
injection containing SEC1 or a mutant (0.01-10 µg/kg) dissolved in
0.9% NaCl. After monitoring rectal temperature for 4 h, an
intravenous injection of endotoxin (Difco) from Salmonella
typhimurium was administered at a dose equal to one-fiftieth of
its LD50 (10 µg/kg). Mortality was monitored for 48 h. Fisher exact probability test was used in the StarView statistical package (Version 4.57, SAS Institute Inc., Cary, NC) to determine statistical significance between treatment groups.
Emesis Assays--
A modification (9) of the standard monkey
feeding assay for SEs (32) was used for comparing the emetic capability
of SEC1 and several representative zinc binding mutants. Toxins (10 µg/ml) were administered in sterile saline to manually restrained young adult (5-10 kg) pigtail monkeys (Macaca
nemestrina) through a nasogastric tube (infant feeding tube; BD
PharMingen). Each animal received 1.0 ml of toxin solution per kg of
body weight so that the dose received was 10 µg/kg. We had determined
previously that this dose of native SEC1 is sufficient to induce emesis
in 100% of animals tested using this technique (9). Animals were returned to their cages following removal of the nasogastric tube and
observed for 24 h.
Proteolysis Susceptibility Assays--
Purified preparations of
SEC1 or mutants were incubated in the presence of trypsin or pepsin to
assess the contribution of zinc binding residues toward overall
conformation and potential stability of SEC1 in the gastrointestinal
tract. The susceptibility to trypsin was assessed as follows. Each
protein (100 µg/ml) was incubated at 37 °C with trypsin type XI
(100 ng/ml) (Sigma Chemical Company) using standard reaction conditions
(25 mM Tris, pH 8.0, 20 mM CaCl2)
as described previously (9). After incubation for desired periods of
time, aliquots were removed, and the digestions were terminated by
boiling (5 min) in SDS-PAGE sample buffer. The extent of proteolysis
was assessed by SDS-PAGE as described above. To assess the relative
liability to pepsin, each toxin or mutant (100 µg/ml) was incubated
(37 °C) with pepsin (50 µg/ml) in a final volume of 100 µl (100 mM sodium acetate buffer, pH 4.5). At selected time points,
aliquots (10 µl) of the digestion mixture were removed, and the
proteins were resolved by SDS-PAGE. Control lanes contained toxin or
mutant proteins removed from reaction mixtures exposed to identical
conditions in the absence of protease.
Structure Determination and Model Refinement--
The structure
was solved by the molecular replacement method using the AMORE program
(33). Our previously determined SEC3 structure2 from another (P1)
crystal form was used as a search model. The refinement of the model
was then continued with the group B factor refinement followed by the
simulated-annealing protocols implemented in X-PLOR (34). The
rebuilding of the model including addition of solvent molecules and a
zinc atom was done on the graphic program O (35). A substantial drop in
the value of Rfree validated inclusion of
individual atomic temperature factor refinement during the final
stages. The program PROCHECK (36) was used to check the quality of the structure. At the end of the refinement, the
crystallographic R-factor was 16.2% and
Rfree was 23.3%. The detailed refinement statistics are shown in Table II. The
atomic coordinates have been deposited in the Protein Data Bank with
the accession code 1ck1.
Overall Structure and a Common Architecture--
The structural
features of SEC3 are very similar to those found in other bacterial
SAgs, characterized by two unequal sized domains. The small domain on
the right (Fig. 1A) has the
fold of a Greek-key beta barrel capped by an Zinc Coordination and Dimerization--
A zinc ligation complex
was found in the structure of SEC3. This complex is located at the
bottom of the cleft between the two domains of SEC3 (Figs. 1 and
2). The zinc atom is coordinated by
Asp-83 from a Alteration of Any of the Three Residues Abrogates Zinc
Binding--
Native SEC1 and each of the five mutant proteins were
assessed for ability to bind zinc using ICP MS as described above.
Similar to results reported for SEC2 (14) the molar ratio of zinc/SEC1 was less than 1.0. Specifically, a mean molar ratio of 0.42 was obtained from multiple replicate experiments, indicating that less than
50% of the SEC1 molecules contained a bound zinc atom (Fig.
3). Analysis of the mutants showed that
zinc binding required the presence of all three native residues at
positions 83, 118, and 122. The amount of zinc in purified single or
double site mutants was dramatically reduced and similar to background
levels detected by ICP MS.
Zinc Binding Is Not Required for in Vivo Toxicity--
SEs are
able to cause either food poisoning or toxic shock syndrome, depending
on the route of exposure to the toxins (1). Mutants SEC1(D83A),
SEC1(H118A), SEC1(H122A), SEC1(D83A/H118A), and SEC1(D83A/H122A) were
tested for their ability to induce emesis in monkeys and to assess the
potential requirement for zinc in inducing food poisoning. SEC1 or
mutants were suspended in 0.9% NaCl and administered into the stomach
of young adult pigtail monkeys using standard techniques (see above).
Each mutant induced emesis in two animals when administered at a
standard screening dose consisting of 10 µg/kg body weight.
Demonstration of fever and lethality in a rabbit model is considered an
indication of SE potential for inducing TSS (40). Several doses
(0.01-10 µg/kg) of SEC1 toxin or mutant toxins were administered to
New Zealand White rabbits via intravenous injection. After 4 h,
during which their rectal temperatures were monitored, a sublethal dose
(10 µg/kg) of S. typhimurium endotoxin was administered via the intravenous route, and the animals were monitored for 48 h. The results summarized in Fig. 4
clearly indicate that zinc binding by the toxin is not required for
induction of lethal shock by SEC1 in this assay. SEC1 and most of the
mutants were lethal at doses as low as 0.1 µg/kg. One mutant
SEC1(D83A) had potency identical to that of native SEC1 in this assay
and induced lethality in 100% of the animals at a low dose of 0.1 µg/kg. SEC1(H122A) was slightly less potent than SEC1 in this assay.
However, it is unlikely that this reduced toxicity was attributed
directly to loss of zinc binding because the SEC1(D83A) mutant had no
significant levels of bound zinc but had a toxicity similar to that of
the native toxin. None of the mutants were lethal at the lowest dose tested (0.1 µg/kg) and were not statistically different from
native SEC1 in this regard (p > 0.9999).
Interestingly, alteration of the zinc binding residues dissociated
lethality and fever induction. Every mutation generated a protein with
a significantly reduced pyrogenic response compared with SEC1, despite
having minimal or no effect on lethality. Even SEC1(D83A), which had a
lethal potency identical to that of SEC1, induced a dramatically
reduced fever response compared with SEC1 at all the doses tested.
Zinc Binding Is Not Necessary for T Cell Proliferation by
SEC1--
Cation binding by SEA and SEE was initially observed because
of their requirement for zinc in induction of T cell proliferation (41). Therefore, it was important to determine whether zinc plays a
similar role in SEC-induced T cell proliferation, and the ability of
the mutants generated in this study to induce proliferation of human
lymphocytes was evaluated.
The differences between the dose-response curves for SEC1 and each of
the substitution mutants were only minimal (Fig.
5). In all cases, maximum proliferation
was with a toxin dose of 1 ng. One substitution H118A caused a minor,
albeit reproducibly stronger, proliferative response at lower doses
compared with SEC1. SEC1(D83A) consistently produced a reduced
mitogenicity dose response curve. Interestingly, the reduced
mitogenicity induced by the D83A substitution could be restored by
introducing a second Ala substitution for His at either position 118 or
122. Both double mutations containing D83A induced levels of T cell
proliferation equal to or above that for SEC1 in lymphocyte
proliferation assays.
Conformational Alterations Induced by the
Mutations--
Initially, each mutant was determined to be
indistinguishable from the native toxin in immunological analyses and
produced a line of identity with SEC1 when analyzed by immunodiffusion assays (26) (results not shown). Furthermore, the retention of
biological activity by all of the mutants generated in this study also
suggested that the native SEC1 structure is not grossly affected by
either the lack of a bound zinc atom or the different properties of the
Ala residue substituted for any three zinc binding residues. Strong
evidence for this is that induction of emesis in the primate model is
expected to require unique native S.E. structural features that allow
these toxins to resist degradation by the harsh conditions in the
gastrointestinal tract.
To extend these results, two protease treatment methods were used to
assess the extent of minor conformational alterations induced by the
mutations in SEC1 generated in this study. First, there was no major
alteration in tryptic susceptibility of any of the five mutants tested
(compared with native SEC1) when exposed to proteolysis by trypsin. The
well characterized major trypsin sensitive sites (42) in native SEC1
were unaltered in regard to rate of hydrolysis, and the profiles of
expected tryptic products generated were identical to those generated
from SEC1 (Fig. 6). The general
conclusion from these experiments was that the zinc atom does not
provide a significant degree of conformational stability to SEC1.
However, further analysis revealed a reduced resistance to pepsin for
some of the mutants. Two mutants with single Ala substitutions for
either His-118 or His-122 demonstrated remarkable resistance to
degradation by pepsin, a characteristic typical of all SEs. Like native
SEC1, these two mutant toxins were stable for at least 24 h in the
presence of pepsin under the conditions employed in this study (Fig.
7). In contrast, the three mutants having
alterations at position 83 degraded at a rate that was significantly
more rapid than native SEC1. Because all five mutants generated in this
study were equally deficient in zinc, the instability resulting from
the D83A mutation is not likely to be the result of absence of the
cation. Instead, it is probably attributed to the inability of Ala to
functionally substitute for Asp at this position and completely
preserve the native SEC1 structure.
Zinc Mutants Lack the Ability to Form Toxin Dimers--
In the
presence of 10 mM ZnCl2, elution of SEC1 in gel
filtration experiments occurred in two distinct peaks, corresponding in
size to monomeric and dimeric forms of the toxin (Fig.
8A). Consistent with earlier
experiments showing that less than half of the SEC1 molecules bound
zinc, approximately one-third of the native toxin eluted from the gel
in an elution volume consistent with the size of a dimer. The remainder
eluted at a point in the profile consistent with a protein of ~27,500
daltons, the size of monomeric SEC1. In contrast, the gel elution
profile of the double mutant SEC1(D83A/H122A) contained only one peak
of protein eluting in a volume consistent with the size of a
monomer.
Results from electrophoretic analyses supported gel filtration
findings. Both SEC1 and the SEC1(D83A/H122A) mutant resolved as single
bands on denaturing SDS-PAGE (Fig. 8B). However, SEC1 applied to native PAGE (Fig. 8B) formed two bands having
intensities consistent with the protein peaks observed in gel
filtration profiles. One protein band, which comprised approximately
one-third of the sample in the gels, represented the dimer while the
remaining two-thirds represented the monomer. In contrast,
SEC1(D83A/H122A) appeared as a single monomeric band in native PAGE.
The crystal structure of SEC3 possessed a structural architecture
common to the SEs. In particular, it shares a high degree of structural
identity to SEC2 (root mean-squared deviation value of 0.34 Å for
backbone atoms when superimposed). It also contained a
dimerization-mediating zinc binding site as seen in the SEC2 structure
that is different from other members of bacterial SAgs.
The low content of zinc in SEC solutions measured by ICP MS and the two
peaks in the gel filtration elution profile indicated that the
monomeric and zinc-mediated dimeric SECs are in equilibrium. This is
consistent with the fact that SEC3 was crystallized into two different
space groups where one space group (P1) exhibited the crystal packing
made of a monomer2 and the other space group
(P4122) showed the dimeric packing (present structure).
Furthermore, abrogation of zinc atom binding by site-directed
mutagenesis resulted in minimal disruption of the protein conformation,
protein stability, and biological activity.
In living systems, zinc is important in catalysis, gene expression, and
immune function (38). In addition, zinc can stabilize the structure of
some proteins and nucleic acids, preserve the integrity of subcellular
organelles, and participate in transport processes (43). Zinc atoms
associated with protein molecules serve two general roles. Structural
zinc atoms such as those in zinc finger motifs are typically
coordinated by cysteines or histidines, while those having a functional
role within a catalytic site are usually coordinated by aspartates,
glutamates, or histidines (43). Because the one found in SECs is held
by two histidines and one aspartate and resembles the configuration of
the catalytic site zinc in thermolysin, it was natural for us to first
speculate the zinc had a functional catalytic role. In fact,
zinc-mediated catalytic activity is inherent to several bacterial
toxins. For example, botulinum and tetanus neurotoxins (44, 45) are
proteases that exert their catalytic activity through a zinc atom.
Similar to the SECs, the zinc atom in these toxins is coordinated by
canonical glutamate and two histidine residues. The anthrax lethal
factor also binds zinc through a thermolysin-like motif (46).
However, no absolute function could be attributed to the zinc in the
SECs by these present studies. To date, the only functional role for
zinc in SEs has been found in the subgroup containing SEA, SED, SEE,
and SEH. The zinc atoms in these SEs and related toxins have been
suggested to mediate their complex formation with MHCII for the SAg
activity. In addition, this function has been proven by the crystal
structures of the SEH-MHCII complex (47) and the SpeC-MHCII complex
(48). In these structures, His-81 from the Contrary to this subgroup of SEs, abrogation of zinc binding through
mutagenesis of SEC1 proved that this metal is dispensable for T cell
proliferation, lethal shock induction, and emesis. Because the zinc
atoms in SECs are involved in homodimerization, this metal does not
seem to be required to bridge the SAg and the SAgs elicit massive T cell proliferation through diverse binding
mechanisms to MHCII and the TCR (50). The MHCII complex mediating zinc
site in SEA, SED, SEE, SEH, and other related SAgs is on the wall of
the There has been evidence suggesting that multimeric interaction of some
superantigens with MHCII and TCR enhances their toxicity (51). Although
the precise implication of SEC homodimerization will require additional
future investigations, our data suggest that the zinc-mediated
homodimerization has a minimal effect on its function. In addition a
catalytic activity also does not appear to be associated with SEC
activity because formation of its homodimer should likely block its
putative substrate binding site. These findings are consistent with the
fact that the related SEB lacks this zinc binding site but still
retains SAg and emetic activities. Therefore, it appears that the zinc
atom in SECs represents a non-functional heavy atom in an exotoxin
group that has diverged from related bacterial toxins containing
crucial zinc atoms. Its presence may reflect evolutionary divergence
from a protein in which zinc had a catalytic or structural role or may
be purely circumstantial.
We thank Dr. Jeff Bolin for helpful
discussions on zinc coordination in metalloproteins. ICP MS analyses
were performed by Melissa Billings and William Siems at the Washington
State University Analytical Services Laboratory. Monkey feeding
experiments were performed at the University of Washington Primate
Research Centers with assistance provided by Debra Glanister, Mark
Mutchison, and Ray Colby. Matt Marshall is acknowledged for his
assistance with statistical analysis.
*
This work was funded by National Research Initiative
Competitive Grants Program United States Department of Agriculture
Grant 9402399, Public Health Service Grants AI28401 and RR00166, the United Dairymen of Idaho, and a grant from the Lucille P. Markey Foundation, given to the Structural Biology Group in the
Department of Biological Sciences.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1ck1) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
Present address: Joslin Diabetes Center, Harvard Medical School,
Boston, MA 02215. To whom correspondence should be
addressed. Tel.: 617-732-2529; Fax: 617-735-1970; E-mail:
young-in.chi@joslin.harvard.edu.
Published, JBC Papers in Press, April 3, 2002, DOI 10.1074/jbc.M201932200
2
Y-I. Chi, G. A. Bohach, and C. V. Stauffacher, unpublished observations.
The abbreviations used are:
SE, staphylococcal
enterotoxin;
TSS, toxic shock syndrome;
SAg, superantigen;
TCR, T cell
receptor;
MHC, major histocompatibility complex;
ICP MS, inductively
coupled plasma mass spectrometry;
SEC, staphylococcal enterotoxin in
the type C serogroup.
Zinc-mediated Dimerization and Its Effect on Activity and
Conformation of Staphylococcal Enterotoxin Type C*
§,
,
, and
Department of Biological Sciences, Purdue
University, West Lafayette, Indiana 47907 and the ¶ Department of
Microbiology, Molecular Biology and Biochemistry, University of Idaho,
Moscow, Idaho 83843
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
sequences of the T cell receptor (TCR) (3, 4). This type of immunostimulation results from specific
interaction of SAgs with the MHC class II molecules (MHCII) on
antigen-presenting cells (APCs) in addition to TCR. Activation of large
numbers of T cells and APCs causes massive release of cytokines, which
contribute to the effects on the cardiovascular and other organ systems
leading to TSS. Some studies have suggested that direct cytotoxicity to
other cells contributes to the pathogenesis of TSS (5, 6).
-sheet wall in the C terminus large domain.
These zinc ligands are conserved among this subgroup of toxins and are
not present in SEB or SEC. In the SED structure, an additional zinc site was found at a site similar to that in the SECs (20). This diversity raises questions as to why the zinc atoms are found at
different places in the structures of this otherwise related group of
toxins. The goal of this present study was to determine the effect of
zinc binding for the structure and function of the SEC group of toxins.
The study included crystallographic analysis of the SEC3 structure and
mutational analysis of the SEC1 zinc binding site.
Zinc binding sites and homodimerization observed in the superantigen
crystal structures
Data processing and refinement statistics
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

mercaptoethanol.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helix at one end. This domain has the same topology and fold as the
oligonucleotide/oligosaccharide binding (OB) fold (37) and contains the
disulfide loop. The larger domain on the left (Fig. 1A) is
an
/
sandwich or
-grasp motif made up of a five-strand mixed
-sheet wall over which a group of
-helices are laid.

View larger version (31K):
[in a new window]
Fig. 1.
Ribbon diagrams of the SEC3 structure with
the prototype orientation from which two distinct domains are best
viewed (A) and with another orientation to show the
monomeric zinc binding site (B). The zinc
atom and ligands are represented as a ball and stick model.
The disulfide bond is also highlighted.
-strand of the small domain and His-118/ His-122, both
from the loop connecting the two domains (Figs. 1 and 2). Unlike the
SEC3 structure in the P1 space group where a water molecule acts as the
fourth ligand (results not shown), the fourth ligand in
P4122 space group is provided by Asp-9 from the neighboring molecule, thus forming a dimer (Fig. 2). The zinc sits in the center of
these residues ~0.80 Å above the plane formed by any three liganding
atoms. Standard metal-ligand distances taken from the structures
refined at high resolution are 2.0-2.3 Å (38). The distance between
the zinc atom in SEC3 and OD1(Asp-83), ND1(His118), NE2(His122), and
OD1(Asp9) is 2.17, 2.22, 2.20, and 2.22 Å, respectively, well within
these standard distances. The two histidines also adopt different
tautomeric conformations in binding the zinc in the toxin structure.
His-118 in SEC3 binds to zinc through ND1 (syn) and His-122
through NE2 (anti). The formation of the dimer (Fig. 2)
buries 590 Å2 of solvent-accessible surface per monomer,
and the noticeable makeup of the dimer interface is the presence of two
salt bridges between Lys-37, Lys-56 from one molecule and Asp-10,
Glu-16 from a neighboring molecule, respectively. Because no divalent
metal ions were added to the crystallization medium, this zinc atom is
believed to be intrinsic, and the homodimerization does not appear to
be an artifact of the crystal environment. The same zinc-mediated
dimerization was observed in the SEC2 crystal structure (14) that was
grown under different conditions. A similar zinc-induced homodimerization has been also observed in human growth hormone (39).

View larger version (33K):
[in a new window]
Fig. 2.
Zinc-mediated dimerization.
A, a ribbon diagram showing the spatial arrangement of the
dimer. The 2-fold axis relating each monomer coincides with the
crystallographic axis resulting in one molecule per asymmetric unit.
B, closeup of the zinc binding site in a dimeric
configuration found in the crystal structure. Asp-9 is from the
neighboring molecule.

View larger version (7K):
[in a new window]
Fig. 3.
Zinc binding by SEC1 and mutants.
Samples (0.2-1.0 mg) of each exhaustively washed protein were analyzed
by ICP MS. Results are reported as a molar ratio of zinc atoms per
protein molecule. Controls consisting of 2 mM HEPES buffer
did not contain detectable levels of zinc. The detection limit for zinc
in this procedure was 0.5 ppb.

View larger version (14K):
[in a new window]
Fig. 4.
Lethality and pyrogenicity of zinc binding
mutants in a rabbit TSS model. Rabbits were given intravenous
injections of various doses (as indicated) of native or mutant SEC1.
The mean rectal temperature rise of the rabbits (3-4/group) was
monitored for 4 h. At the 4-h time point, a sublethal dose (10 µg/kg) of S. typhimurium endotoxin was administered.
Fractions on the right refer to the number of animals per
total number of animals injected that succumbed within 3 days following
administration of the toxins. The results of experiments employing four
different doses: 10 µg/kg (A), 1 µg/kg (B),
0.1 µg/kg (C), 0.01 µg/kg (D) of SEC1 or
mutant toxin are given in separate panels.

View larger version (21K):
[in a new window]
Fig. 5.
Comparison of T cell proliferative responses
induced by native SEC1 and mutants. T cells from a human donor
were incubated for 4 days in cultures supplemented with SEC1 or a
mutant. Cellular proliferation was measured by
[3H]thymidine incorporated into cellular DNA during the
final 24 h of incubation. Data points are the average of four
replicate test wells (± S.E.M.). These data were derived from a
representative experiment comparing the proliferative response induced
by native SEC1 and single site mutants (A) and all three
mutants (B) altered at position 83. Each mutant toxin was
tested in multiple experiments at least four times, and the same
pattern was observed with each replicate.

View larger version (72K):
[in a new window]
Fig. 6.
Trypsin sensitivity of SEC1 and zinc binding
mutants. Each protein (100 µg/ml) was incubated (37 °C) with
trypsin type XI (100 ng/ml) as described in the text. At selected time
points, aliquots (10 µl) were removed, boiled in SDS-PAGE sample
buffer, and analyzed by SDS-PAGE.

View larger version (78K):
[in a new window]
Fig. 7.
Relative liability of native SEC1 and mutants
to proteolysis by pepsin. Each toxin or mutant (100 µg/ml) was
incubated (37 °C) with pepsin (50 µg/ml) in a final volume of
100:l (100 mM sodium acetate buffer pH 4.5). At selected
time points, aliquots (10 µl) of the digestion mixture were removed
and resolved by SDS-PAGE. Control lanes contain toxin or
mutant removed from reaction mixtures exposed to identical conditions
in the absence of protease.

View larger version (71K):
[in a new window]
Fig. 8.
Gel filtration, SDS-PAGE and native PAGE used
to detect monomer and dimer forms of native and mutant SEC1.
A, Sephadex G-75 elution profile of SEC1 and mutant
SEC1(D83A/H122A) indicates the ability of the native toxin to form
dimers and the inability of the mutant to do so. Arrows
indicate the elution of protein size standards. B, SEC1 and
SEC1(D83A/H122A) appear as single, monomer-sized bands when analyzed by
SDS-PAGE, whereas SEC1 and SEC1(D83A/H122A) analyzed by native PAGE
resolve as a single band (mutant) or a doublet (SEC1), showing their
differential ability to form dimers. Arrows in SDS-PAGE
indicate the location of protein size standards and their molecular
masses.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-chain of MHCII serves as
the fourth zinc ligand and contributes to the complex formation.
-chain of MHCII. The
minor differences observed in proliferative ability for the mutants
occurred independent of the presence of a bound zinc atom. The most
likely explanation for these differences is that subtle conformational
alterations were induced by the Ala substitutions. Results from
proteolysis studies support this possibility and suggest that certain
conformational alterations could affect interaction of these SAgs with
crucial receptors on immune cells in a variable manner.
-grasp C-terminal domain and different from the one in SECs
(Table I). However, the crystal structure of the SEB-MHCII complex (49)
displayed a different MHCII binding mode that is unique in this
subgroup of SAgs including SECs. The interaction is made through the
oligomer binding surface of the OB fold, remote from any zinc binding
sites of SEs. Although the exact binding mode of SECs with MHCII is not
known at the moment, a similar binding mode is expected from the
sequence homology and similar TCR V
specificity with SEB (50). Thus,
these findings establish SECs along with SEB as another subgroup of SEs
in which the MHCII binding does not require zinc.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Present address: Integrated Genomics, Inc. 2201 W. Campbell
Park Dr., Chicago, IL 60612.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Bohach, G. A.,
Fast, D. J,
Nelson, R. D.,
and Schlievert, P. M.
(1990)
Crit. Rev. Microbiol.
17,
251-272[Medline]
[Order article via Infotrieve]
2.
Jablonski, L. M.,
and Bohach, G. A.
(1997)
in
Food Microbiology: Fundamentals and Frontiers
(Doyle, M. P.
, Beuchat, L. P.
, and Montville, T. J., eds)
, pp. 353-375, ASM Press, Washington, D. C.
3.
White, J.,
Herman, A.,
Pullen, A. M.,
Kubo, R.,
Kappler, J. W.,
and Marrack, P.
(1989)
Cell
56,
27-35[CrossRef][Medline]
[Order article via Infotrieve]
4.
Monday, S. R.,
and Bohach, G. A.
(1999)
in
The Comprehensive Sourcebook of Bacterial Toxins
(Alouf, J. E.
, and Freer, J. H., eds)
, pp. 589-610, Academic Press, London
5.
Kushnaryov, V. M.,
Macdonald, H. M.,
Reiser, R. F.,
and Bergdoll, M. S.
(1989)
Rev. Infect. Dis.
11 Suppl. 1,
S282-S287[Medline]
[Order article via Infotrieve]
6.
Lee, P. K.,
Vercellotti, G. M.,
Deringer, J. R.,
and Schlievert, P. M.
(1991)
J. Infect. Dis.
164,
711-719[Medline]
[Order article via Infotrieve]
7.
Alber, G.,
Hammer, D. K.,
and Fleischer, B.
(1990)
J. Immunol.
144,
4501-4506[Abstract]
8.
Harris, T. O.,
Grossman, D.,
Kappler, J. W.,
Marrack, P.,
Rich, R. R.,
and Betley, M. J.
(1993)
Infect. Immun.
61,
3175-3183 9.
Hovde, C. J.,
Marr, J. M.,
Hoffman, M. L.,
Hackett, S. P.,
Chi, Y.-I.,
Crum, K. K.,
Stevens, D. L.,
Stauffacher, C. V.,
and Bohach, G. A.
(1994)
Mol. Microbiol.
13,
897-909[CrossRef][Medline]
[Order article via Infotrieve]
10.
Scheuber, P. H.,
Denzlinger, C.,
Wilker, D.,
Beck, G.,
Keppler, D.,
and Hammer, D. K.
(1987)
Eur. J. Clin. Invest.
17,
455-459[Medline]
[Order article via Infotrieve]
11.
Scheuber, P. H.,
Denzlinger, C.,
Wilker, D.,
Beck, G.,
Keppler, D.,
and Hammer, D. K.
(1987)
Int. Arch. Allergy Appl. Immunol.
82,
289-291[Medline]
[Order article via Infotrieve]
12.
Jett, M.,
Brinkley, W.,
Neill, R.,
Gemski, P.,
and Hunt, R.
(1990)
Infect. Immun.
58,
3494-3499 13.
Edwards, V. M.,
Deringer, J. R.,
Callantine, S. D.,
Deobald, C. F.,
Berger, P. H.,
Kapur, V.,
Stauffacher, C. V.,
and Bohach, G. A.
(1997)
Infect. Immun.
65,
2346-2352[Abstract]
14.
Papageorgiou, A. C.,
Acharya, K. R.,
Shapiro, R.,
Passalacqua, E. F.,
Brehm, R. D.,
and Tranter, H. S.
(1995)
Structure
3,
769-779[Medline]
[Order article via Infotrieve]
15.
Bohach, G. A.,
Jablonski, L. M.,
Deobald, C. F.,
Chi, Y.-I.,
and Stauffacher, C. V.
(1995)
in
Molecular Approaches to Food Safety; Issues Involving Toxic Microorganisms
(Ecklund, M.
, Richard, J. L.
, and Mise, K., eds)
, pp. 339-356, Alaken Inc., Fort Collins, CO
16.
Swaminathan, S.,
Furey, W.,
Pletcher, J.,
and Sax, M.
(1992)
Nature
359,
801-806[CrossRef][Medline]
[Order article via Infotrieve]
17.
Papageorgiou, A. C.,
Tranter, H. S.,
and Acharya, K. R.
(1998)
J. Mol. Biol.
277,
61-79[CrossRef][Medline]
[Order article via Infotrieve]
18.
Schad, E. M.,
Zaitseva, I.,
Zaitsev, V. N.,
Dohlsten, M.,
Kalland, T.,
Schlievert, P. M.,
Ohlendorf, D. H.,
and Svensson, L. A.
(1995)
EMBO J.
14,
3292-3301[Medline]
[Order article via Infotrieve]
19.
Sundström, M.,
Hallèn, D.,
Svensson, A.,
Schad, E.,
Dohlsten, M.,
and Abrahmsèn, L.
(1996)
J. Biol. Chem.
271,
32212-32216 20.
Sundström, M.,
Abrahmsén, L.,
Antonsson, P.,
Mehindate, K.,
Mourad, W.,
and Dohlsten, M.
(1996)
EMBO J.
15,
6832-6840[Medline]
[Order article via Infotrieve]
21.
Swaminathan, S.,
Furey, W.,
Pletcher, J.,
and Sax, M.
(1995)
Nat. Struct. Biol.
2,
680-686[CrossRef][Medline]
[Order article via Infotrieve]
22.
Hakansson, M.,
Petersson, K.,
Nilsson, H.,
Forsberg, G.,
Bjork, P.,
Antonsson, P.,
and Svensson, A.
(2000)
J. Mol. Biol.
302,
527-537[CrossRef][Medline]
[Order article via Infotrieve]
23.
Marr, J. C.,
Lyon, J. D.,
Roberson, J. R.,
Lupher, M.,
Davis, W. C.,
and Bohach, G. A.
(1993)
Infect. Immun.
61,
4254-4262 24.
Bohach, G. A.,
Chi, Y.-I.,
and Stauffacher, C. V.
(1992)
Proteins
13,
152-157[CrossRef][Medline]
[Order article via Infotrieve]
25.
Kabsch, W.
(1988)
J. Appl. Crystallogr.
2,
916-924
26.
Bohach, G. A.,
and Schlievert, P. M.
(1987)
Infect. Immun.
55,
428-432 27.
Hovde, C. J.,
Hackett, S. P.,
and Bohach, G. A.
(1990)
Mol. Gen. Genet.
220,
329-333[CrossRef][Medline]
[Order article via Infotrieve]
28.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
29.
Jarvis, K. E.,
Gray, A. L.,
and Houk, R. S.
(1991)
Handbook of Inductively Coupled Plasma-Mass Spectrometry
, Chapman & Hall, Glasgow and London
30.
Poindexter, N. J.,
and Schlievert, P. M.
(1985)
J. Infect. Dis.
151,
65-72[Medline]
[Order article via Infotrieve]
31.
Kim, Y. B.,
and Watson, D. W.
(1970)
J. Exp. Med.
131,
611-628[Abstract]
32.
Bergdoll, M. S.
(1988)
Methods Enzymol.
165,
324-333[Medline]
[Order article via Infotrieve]
33.
Navaza, J.
(1994)
Acta Crystrallogr.
D50,
157-163
34.
Brünger, A. T.
(1992)
X-PLOR Manual Version 3.1
, Yale University, New Haven, CT
35.
Jones, T. A.,
Zhou, J.-Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr.
A47,
110-119
36.
Laskowski, R. A.,
Macarthur, M. W.,
Moss, D. S.,
and Thorton, J. M.
(1993)
J. Appl. Crystallogr.
A26,
283-291
37.
Murzin, A. G.
(1993)
EMBO J.
12,
861-867[Medline]
[Order article via Infotrieve]
38.
Vallee, B. L.,
and Auld, D. S.
(1990)
Biochemistry
29,
5647-5659[CrossRef][Medline]
[Order article via Infotrieve]
39.
Cunningham, B. C.,
Mulkerrin, M. G.,
and Wells, J. A.
(1991)
Science
253,
545-548 40.
Schlievert, P. M.
(1982)
Infect. Immun.
36,
123-128 41.
Fraser, J. D.,
Urban, R. G.,
Strominger, J. L.,
and Robinson, H.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5507-5511 42.
Bohach, G. A.,
Handley, J. P.,
and Schlievert, P. M.
(1989)
Infect. Immun.
57,
23-28 43.
Coleman, J. E.
(1992)
Annu. Rev. Biochem.
61,
897-946[CrossRef][Medline]
[Order article via Infotrieve]
44.
Lacy, D. B.,
Tepp, W.,
Cohen, A. C.,
DasGupta, B. R.,
and Stevens, R. C.
(1998)
Nat. Struct. Biol.
5,
898-902[CrossRef][Medline]
[Order article via Infotrieve]
45.
Tonello, F.,
Morante, S.,
Rossetto, O.,
Schiavo, G.,
and Montecucco, C.
(1996)
Adv. Exp. Med. Biol.
89,
251-260
46.
Binz, T.,
Kurazono, H.,
Popoff, M. R.,
Eklund, M. W.,
Sakaguchi, G.,
Kozaki, S.,
Krieglstein, K.,
Gill, D. M.,
and Niemann, H.
(1990)
Nucleic Acids Res.
18,
5556 47.
Petersson, K.,
Håkansson, M.,
Nilsson, H.,
Forsberg, G.,
Svensson, L. A.,
Liljas, A.,
and Walse, B.
(2001)
EMBO J.
21,
3306-3312[CrossRef]
48.
Li, Y., Li, H.,
Dimasi, N.,
McCormick, J. K.,
Martin, R.,
Schuck, P.,
Schlievert, P. M.,
and Mariuzza, R. A.
(2001)
Immunity
14,
93-104[CrossRef][Medline]
[Order article via Infotrieve]
49.
Jardetzky, T. S.,
Brown, J. H.,
Gorga, J. C.,
Stern, L. J.,
Urban, R. G.,
Chi, Y.-I,
Stauffacher, C. V,
Strominger, J. L.,
and Wiley, D. C.
(1994)
Nature
368,
711-718[CrossRef][Medline]
[Order article via Infotrieve]
50.
Sundberg, E. J., Li, Y.,
and Mariuzza, R. A.
(2002)
Curr. Opin. Immunol.
14,
36-44[CrossRef][Medline]
[Order article via Infotrieve]
51.
Papageorgiou, A. C.,
and Acharya, K. R.
(2000)
Trends Microbiol.
8,
369-375[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Jin, G. A. Bohach, J. Shiloach, S. E. Norris, D. I. Freedberg, C. Deobald, B. Coxon, J. B. Robbins, and R. Schneerson Conjugates of Group A and W135 Capsular Polysaccharides of Neisseria meningitidis Bound to Recombinant Staphylococcus aureus Enterotoxin C1: Preparation, Physicochemical Characterization, and Immunological Properties in Mice Infect. Immun., December 1, 2005; 73(12): 7887 - 7893. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hong-Geller, M. Mollhoff, P. R. Shiflett, and G. Gupta Design of Chimeric Receptor Mimics with Different TcRV{beta} Isoforms: TYPE-SPECIFIC INHIBITION OF SUPERANTIGEN PATHOGENESIS J. Biol. Chem., February 13, 2004; 279(7): 5676 - 5684. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Papageorgiou, M. D. Baker, J. D. McLeod, S. K. Goda, C. N. Manzotti, D. M. Sansom, H. S. Tranter, and K. R. Acharya Identification of a Secondary Zinc-binding Site in Staphylococcal Enterotoxin C2: IMPLICATIONS FOR SUPERANTIGEN RECOGNITION J. Biol. Chem., January 9, 2004; 279(2): 1297 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Surdo, M. J. Bottomley, M. Sattler, and K. Scheffzek Crystal Structure and Nuclear Magnetic Resonance Analyses of the SAND Domain from Glucocorticoid Modulatory Element Binding Protein-1 Reveals Deoxyribonucleic Acid and Zinc Binding Regions Mol. Endocrinol., July 1, 2003; 17(7): 1283 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Langlois, Y. E. Fakhry, and W. Mourad Zinc-binding Sites in the N Terminus of Mycoplasma arthritidis-derived Mitogen Permit the Dimer Formation Required for High Affinity Binding to HLA-DR and for T Cell Activation J. Biol. Chem., June 13, 2003; 278(25): 22309 - 22315. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Swietnicki, A. M. Barnie, B. K. Dyas, and R. G. Ulrich Zinc Binding and Dimerization of Streptococcus pyogenes Pyrogenic Exotoxin C Are Not Essential for T-cell Stimulation J. Biol. Chem., March 7, 2003; 278(11): 9885 - 9895. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||